DongKook Life Science Co

DongKook Life Science Co FCF per Share

The Free Cash Flow per Share of DongKook Life Science Co (303810.KQ) as of Nov 5, 2026 is -164.37 KRW. In the previous year, Free Cash Flow per Share was 201.81 KRW — a change of -181.45% (lower).

FCF per Share

-164.37KRW

YoY

-181.45%

Last updated:

Free Cash Flow per Share of DongKook Life Science Co is 2025 -164.37 KRW. Free Cash Flow per Share of DongKook Life Science Co was 2024 201.81 KRW. It decreases by -181.45% lower compared to the previous year.

The DongKook Life Science Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2022
-634.54 KRW
Jan 1, 2023
-293.84 KRW
Jan 1, 2024
201.81 KRW
Jan 1, 2025
-164.37 KRW
The DongKook Life Science Co FCF per Share history
YEARFCF per ShareYoY
-164.37KRW-181.45%
201.81KRW-168.68%
-293.84KRW-53.69%
-634.54KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DongKook Life Science Co Stock analysis

What does DongKook Life Science Co do? DongKook Life Science Co Ltd generates revenue through the production and sale of contrast agents, including X-ray contrast agents and magnetic resonance imaging (MRI) contrast agents, alongside the distribution and sale of medical equipment and medical devices. The company serves healthcare providers and medical institutions that require diagnostic imaging solutions, focusing on the Korean market with its Seoul headquarters. Its primary products are contrast agents for medical imaging procedures, which are essential for diagnostics in hospitals and clinics. The firm's business model centers on supplying specialized medical products to the healthcare sector, leveraging its expertise in contrast agent manufacturing. By offering both imaging contrast agents and complementary medical equipment, DongKook Life Science targets hospitals and diagnostic centers seeking comprehensive imaging solutions. The company's operations are rooted in the production of medical imaging tools that support diagnostic procedures in Korea. DongKook Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DongKook Life Science Co stock

Free Cash Flow per Share of DongKook Life Science Co is -164.37 KRW in 2025.

Free Cash Flow per Share of DongKook Life Science Co changed from 201.81 KRW to -164.37 KRW, representing a -181.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share DongKook Life Science Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — DongKook Life Science Co

All Key Metrics — DongKook Life Science Co